<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="other"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Med Gas Res</journal-id><journal-id journal-id-type="publisher-id">MGR</journal-id><journal-id journal-id-type="publisher-id">Med Gas Res</journal-id><journal-title-group><journal-title>Medical Gas Research</journal-title></journal-title-group><issn pub-type="epub">2045-9912</issn><publisher><publisher-name>Wolters Kluwer - Medknow</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC466980</article-id><article-id pub-id-type="publisher-id">MGR-14-159</article-id><article-id pub-id-type="doi">10.4103/mgr.mgr_23_23</article-id><article-categories><subj-group subj-group-type="heading"><subject>Perspective</subject></subj-group></article-categories><title-group><article-title>Protective role of methane in traumatic nervous system diseases</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Lu</surname><given-names>Xurui</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Hu</surname><given-names>Weiliang</given-names></name><xref rid="aff1" ref-type="aff"/><xref rid="fn1" ref-type="author-notes">#</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xuejian</given-names></name><xref rid="aff1" ref-type="aff"/></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Wang</surname><given-names>Zhifeng</given-names></name><degrees>MD</degrees><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-9375-3906</contrib-id><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Yang</surname><given-names>Pingyu</given-names></name><degrees>MS</degrees><xref rid="aff1" ref-type="aff"/><xref rid="cor1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Wenjie</given-names></name><xref rid="aff1" ref-type="aff"/></contrib></contrib-group><aff id="aff1">Department of Neurosurgery, Second Affiliated Hospital of Nantong University, Nantong, Jiangsu Province, China</aff><author-notes><corresp id="cor1"><label>*</label><italic toggle="yes"><bold>Correspondence to:</bold> Zhifeng Wang, <email xlink:href="maisui1976@163.com">maisui1976@163.com</email>; Pingyu Yang, <email xlink:href="542017195@qq.com">542017195@qq.com</email></italic>.</corresp><fn id="fn1"><label>#</label><p><italic toggle="yes">Both authors contributed equally to this work</italic>.</p></fn></author-notes><pub-date pub-type="collection"><season>Jul-Sep</season><year>2024</year></pub-date><pub-date pub-type="epub"><day>20</day><month>3</month><year>2024</year></pub-date><volume>14</volume><issue>3</issue><fpage>159</fpage><lpage>162</lpage><history><date date-type="received"><day>19</day><month>4</month><year>2023</year></date><date date-type="rev-recd"><day>15</day><month>5</month><year>2023</year></date><date date-type="accepted"><day>24</day><month>11</month><year>2023</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; 2024 Medical Gas Research</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions></article-meta></front><body><p>Methane, an odorless, colorless, tasteless gas under standard state, is the simplest hydrocarbon.<xref rid="R1" ref-type="bibr">1</xref> It is a very potential fuel that constitutes the main component of natural gas. Since the discovery of methane in 1778, it is generally believed that methane is a physiologically inert gas with stable chemical properties and does not participate in biological metabolism.<xref rid="R2" ref-type="bibr">2</xref> So for years, little research has focused on the role of methane in the clinical field.<xref rid="R3" ref-type="bibr">3</xref> Until 2012, Boros et al.<xref rid="R4" ref-type="bibr">4</xref> carried out a preliminary research on the physiological effects of methane and found that methane has anti-inflammatory and anti-oxidation stress effects in intestinal ischemia/reperfusion injury. Subsequently, Ye et al.<xref rid="R5" ref-type="bibr">5</xref> found that methane could inhibit inflammation and apoptosis after hepatic ischemia/reperfusion injury. Since then, an increasing number of papers have shown that methane has biological activity and can protect cells and organs from inflammation, oxidation stress and apoptosis damage, indicating that methane has a certain therapeutic effect on various clinical diseases during the basic research stage.</p><p>Methane is a lipid-soluble gas molecule that has the ability to pass through the cell membrane and spread to the organelles,<xref rid="R6" ref-type="bibr">6</xref> which means that methane can reach the DNA and mitochondria, let alone the BBB and the blood-spinal cord barrier. Wang and his colleagues<xref rid="R7" ref-type="bibr">7</xref> used methane-rich saline (MS) to treat spinal cord injury (SCI) and found that MS could stay in the spinal cord for 10 hours after only 72 minutes of irrigation, showing good biocompatibility. Therefore, MS is suitable for the treatment of nervous system diseases. In addition, methane in the body is essentially non-toxic. In this way of injecting intraperitoneally at a micromolar dose, methane does not change the arterial oxygen tension, arterial carbon dioxide tension, pH, plasma glucose and hematocrit, which confirms the security of methane.<xref rid="R8" ref-type="bibr">8</xref> In summary, methane has hypertonicity, good biocompatibility and safety, which makes it a very promising method for treating nervous system diseases.</p><p>It is worth noting that although human clinical experiments on the function of methane in neurological diseases have not yet begun, the basic research on methane in traumatic neurological diseases, including traumatic SCI (TSCI),<xref rid="R7" ref-type="bibr">7</xref> traumatic brain injury (TBI)<xref rid="R9" ref-type="bibr">9</xref> and optic nerve crush (ONC),<xref rid="R10" ref-type="bibr">10</xref> has become more profound in recent years (<bold><xref rid="mgr.mgr_23_23-T1" ref-type="table">Table 1</xref></bold>). Therefore, giving further clarification on the neuroprotective effects is of great significance for methane as a new drug to treat nervous system diseases. In this context, we summarize and discuss the protective effects of methane on traumatic nervous system diseases and its possible mechanism in treating neurological diseases by retrieving previously published documents and databases. At the same time, in this perspective, to promote safe and effective use in clinical area, we propose the existing problems in the application of methane and suggest future directions for methane research.</p><table-wrap position="float" id="mgr.mgr_23_23-T1"><label>Table 1</label><caption><p>Mechanisms of action of methane in disease treatment</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1">Anti-inflammation</th><th align="left" rowspan="1" colspan="1">Anti-oxidation</th><th align="left" rowspan="1" colspan="1">Anti-cell death</th><th align="left" rowspan="1" colspan="1">Reference</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Spinal cord injury</td><td align="left" rowspan="1" colspan="1">Interleukin-1&#x003b2;, tumor necrosis factor-&#x003b1;, interleukin-6, ionized calcium binding adaptor molecule-1</td><td align="left" rowspan="1" colspan="1">Malondialdehyde, superoxide dismutase</td><td align="left" rowspan="1" colspan="1">Caspase-3</td><td align="left" rowspan="1" colspan="1">Wang et al.<xref rid="R7" ref-type="bibr">7</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Traumatic brain injury</td><td align="left" rowspan="1" colspan="1">Interleukin-1&#x003b2;, tumor necrosis factor-&#x003b1;, interleukin-6, Wnt pathway</td><td align="left" rowspan="1" colspan="1">Superoxide dismutase, Wnt pathway</td><td align="left" rowspan="1" colspan="1">Caspase-3, Wnt pathway</td><td align="left" rowspan="1" colspan="1">Li et al.<xref rid="R9" ref-type="bibr">9</xref></td></tr><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Tumor necrosis factor-&#x003b1;, interleukin- 1&#x003b2;, interleukin-6, Janus kinase 1/signal transducer and activator of transcription 1/ nuclear factor-&#x003ba;B-p65 pathway</td><td align="left" rowspan="1" colspan="1">Malondialdehyde, 3-nitrotyrosine, 8-hydroxy-2- deoxyguanosine, superoxide dismutase</td><td align="left" rowspan="1" colspan="1">Caspase-3, Bax, Bcl-2</td><td align="left" rowspan="1" colspan="1">Wang et al.<xref rid="R13" ref-type="bibr">13</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Optic nerve crush</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Phosphorylated Bad, phosphorylated glycogen synthase kinase-3&#x003b2;, Bax, Bcl-xL</td><td align="left" rowspan="1" colspan="1">Wang et al.<xref rid="R10" ref-type="bibr">10</xref></td></tr></tbody></table></table-wrap><p>
<bold>Methane plays a crucial role following central nervous system trauma</bold>
</p><p><bold><italic toggle="yes">Neuroprotective role of methane in TSCI:</italic></bold> TSCI is a destructive nervous system disease.<xref rid="R11" ref-type="bibr">11</xref> The neurological mechanism of TSCI is very complicated. Initial trauma leads to acute cell dysfunction or death, and a large number of inflammatory cells and microglial cells, once activated, can release inflammatory factors such as interleukin (IL)-1&#x003b2;, IL-6 and tumor necrosis factor-&#x003b1;, leading to the inflammatory cascade, which thereby results in secondary SCI.<xref rid="R12" ref-type="bibr">12</xref></p><p>At the same time, reactive oxygen species (ROS) can cause cell damage and spinal cord dysfunction. Therefore, the focus of SCI is to minimize the oxidation stress and inflammatory response of secondary damage.<xref rid="R7" ref-type="bibr">7</xref> At the same time, a related study has shown that the reduction of apoptosis, especially neuronal cell apoptosis, could significantly improve the prognosis of TSCI.<xref rid="R7" ref-type="bibr">7</xref></p><p>Wang et al.<xref rid="R7" ref-type="bibr">7</xref> constructed SCI rat models and confirmed that the levels of superoxide dismutase and malondialdehyde, as well as the levels of TNF-&#x003b1;, IL-1&#x003b2;, and IL-6, were significantly increased after 72 hours of damage. MS could downregulate the content of oxidation stress factors and inflammatory factors 72 hours after SCI, and also found that intraperitoneal injection with MS could significantly inhibit the apoptosis, and its concentration was significantly effective at 20 mL/kg. To further explore the protection mechanism of MS for SCI, researchers tested microglial cells after SCI, and found them activated in SCI areas 72 hours and 2 weeks, and MS could weaken microglial activation. In addition, Wang et al.<xref rid="R7" ref-type="bibr">7</xref> confirmed that the use of MS to treat SCI could help improve locomotor function, especially in the early stages of SCI. The sooner the MS was administered, the better the protection effects. However, these results <italic toggle="yes">in vivo</italic> have not yet received the support of methane&#x02019;s neurological protection <italic toggle="yes">in vitro</italic>. The results of the above research suggested that after SCI, MS could reduce the oxidation stress, inflammatory level and apoptosis by inhibiting the microglial activation, and protecting against SCI. Nevertheless, since the exact molecular and signaling pathway mechanisms of the neuroprotective effect of methane in the SCI animal model is unclear, further research should be conducted to clarify how methane plays neuroprotection against SCI. According to reports, MS could alleviate traumatic brain damage by blocking the activation of the Janus kinase 1/signal transducer and activator of transcription 1/nuclear factor-&#x003ba;B-P65 pathway.<xref rid="R13" ref-type="bibr">13</xref> Methane was used in cerebral ischemia/reperfusion injury damage resting upon the phosphoinositide 3-kinase/Akt/heme oxygenase-1 pathway.<xref rid="R14" ref-type="bibr">14</xref> Another study reported that bone marrow mesenchymal stem cell transplantation could effectively restore motor function after SCI by activating the phosphoinositide 3-kinase/AKT/mammalian target of rapamycin pathway.<xref rid="R15" ref-type="bibr">15</xref> The verification of conduction pathways as described above opened the idea for research in the field of SCI. Clearing this problem may help find the new target of methane effects, so as to find a new method for treating neuronal damage after SCI.</p><p><bold><italic toggle="yes">Neuroprotective effects of methane in TBI:</italic></bold> TBI is one of the main causes of death and disability. Ameliorate inflammation reactions, oxidation stress and apoptosis are very important for the treatment of TBI.<xref rid="R16" ref-type="bibr">16</xref> However, no effective drugs have been approved. Methane may be a potential drug for this purpose.</p><p>The research results showed that the neurological severity score in the MS group increased, the residual neurons and the superoxide dismutase increased, while the expression of TNF-&#x003b1;, IL-1, IL-6 and apoptosis signaling molecules decreased, which proved that MS could inhibit the release of inflammatory factors, exert antioxidant effects, maintain the normal structure of neurons, and restrain cell apoptosis after TBI, thereby promoting the improvement of the nerve function.<xref rid="R9" ref-type="bibr">9</xref> The group found that a concentration of 20 mL/kg had the strongest protective effect, and increasing the dosage to 30 mL/kg did not improve its effects. In a subsequent study, Li et al.<xref rid="R9" ref-type="bibr">9</xref> also found that these functions of MS may be mediated by the Wnt pathways. Because the Wnt pathway suppression could weaken the moderating effects of MS on oxidative stress, neuroinflammation, and apoptosis, it could not be eliminated, which highlights the possibility of other signal routings.<xref rid="R9" ref-type="bibr">9</xref> This study was conducted the role of MS in the early and middle stages of TBI. Therefore, further experiments should focus on the post-stage of TBI. In addition, the significant results between the 2 mL/kg MS treatment group and the 20 mL/kg MS treatment group reflected the dose-dependent effects of methane protection, but Fan and others<xref rid="R17" ref-type="bibr">17</xref> believed that 10 mg/kg was the best dose. This different result might be due to using different animal models and dosing frequency. The specific dose still needs further studies to confirm it, so that methane can be used in clinical trials.</p><p>Secondly, in another study by Wang et al.<xref rid="R13" ref-type="bibr">13</xref> the intraperitoneal injection of methane was proved to improve the cognitive function of TBI in the Morris water maze test, reduce the blurring of brain tissues boundary, the number of necrotic plaques and neurons in TBI rats. Treatment with methane can downregulate malondial-dehyde, 3-nitrotyrosine and 8-hydroxy-2-deoxyguanosine, also caspase-3 and Bax protein levels, change over TNF-&#x003b1;, IL-&#x00399;&#x003b2; and IL-6, while upregulating superoxide dismutase and Bcl-2 levels, by blocking the activation of Janus kinase 1/signal transducer and activator of transcription 1/nuclear factor-&#x003ba;B-P65. Subsequently, MS improved cognitive function, reduced inflammatory response and oxidation stress, and inhibited apoptosis.<xref rid="R13" ref-type="bibr">13</xref> In addition to cell death, oxidation stress and inflammation, recent research results show that ferroptosis is a new form of secondary brain injury after TBI, which provides new therapeutic targets for protecting damaged brain.<xref rid="R18" ref-type="bibr">18</xref> Whether methane can act on ferrostatin-1, thereby inhibiting ferroptosis and exerting neuroprotective effects will be the next step. Also, MS had a protective effect on brain injury by inhibiting the apoptosis guided by the endoplasmic reticulum stress. Further exploration can be made to see if the protective effect of methane against TBI is related to endoplasmic reticulum stress-mediated apoptosis.<xref rid="R19" ref-type="bibr">19</xref></p><p><bold><italic toggle="yes">Neuroprotective effects of methane in ONC:</italic></bold> ONC is extremely common among patients with trauma at the head and face region. Due to the limitations of nerve regeneration capacity, the therapeutic options focus on protecting early neuron cells and inhibiting later apoptosis.<xref rid="R20" ref-type="bibr">20</xref> Constructing a mouse ONC model, Wang et al.<xref rid="R10" ref-type="bibr">10</xref> subjected the mice to a battery of tests that were used routinely to measure the nerve protection effect of methane, and proved that methane therapy could promote the survival of the retinal ganglion cells after ONC, improve the visual dysfunction caused by ONC. Also, slowing down the apoptosis process of retinal ganglion cells, promoting mitochondrial steady state caused by ONC, these above could testify that the nerve protection of methane might be related to the improvement of mitochondrial dysfunction.<xref rid="R10" ref-type="bibr">10</xref> Methane might be a potential neuroprotective agent of traumatic optic neuropathy and glaucomatous optic atrophy.</p><p>
<bold>Points of interaction between traumatic neurological disorders</bold>
</p><p><bold><italic toggle="yes">Microglia run through the traumatic neurological disorders:</italic></bold> Microglia, are the resident macrophages of the central nervous system, which are also congenital immune cells in the human brain.<xref rid="R21" ref-type="bibr">21</xref> They play a vital role in secondary damage after the traumatic injury of the central nervous system. Microglia are essential for the restoration of tissue stability and the best recovery after SCI.<xref rid="R22" ref-type="bibr">22</xref> Research shows that microglia could also promote the neuron stabilization of TBI.<xref rid="R23" ref-type="bibr">23</xref> When microglia are activated, they will polarize to proinflammatory M1 and anti-inflammatory M2 phenotypes. Under the influence of certain pathological factors, if microglia are in activation for a long time, the proportional disorders of M1 and M2 cells will lead to an imbalance in the central immune system.<xref rid="R24" ref-type="bibr">24</xref> The final ending is to cause neuronal lesions or death. In addition to being activated by neuroinflammation, microglia are also major contributors to the oxidative stress of central nervous system, and the sources of ROS production are diverse,<xref rid="R25" ref-type="bibr">25</xref> such as intracellular peroxidase and membrane surface nicotinamide adenine dinucleotide phosphate oxidase.<xref rid="R26" ref-type="bibr">26</xref> Besides that, studies have shown that oxygen-glucose deprivation-induced microglia produce large amounts of ROS and malondialdehyde, damaging the microglia themselves, and causing glial cell dysfunction, which may affect the fixed process of nerves.<xref rid="R27" ref-type="bibr">27</xref></p><p>It can be said that the double-sided roles of microglia play a pivotal role in traumatic neurological diseases, and given the antiinflammatory and oxidative stress effects of methane, researchers can further study the role of methane in the balance of M1 and M2 types.<xref rid="R28" ref-type="bibr">28</xref> By harnessing the protective or repairing effects of these reactions while inhibiting their harmful effects, we may be able to control the progression and exacerbation of inflammatory and oxidative stress, and protect living brain tissue.</p><p><bold><italic toggle="yes">Methane is effective in traumatic neurological disorders:</italic></bold> Methane is effective in terms of being against inflammation, oxidative stress and apoptosis in traumatic neurological disorders. In neurological diseases, the occurrence of neuroinflammation is often accompanied by the participation of oxidative stress, and the two are interdependent. ROS is necessary for neuronal differentiation and neuronal signaling.<xref rid="R29" ref-type="bibr">29</xref> It has been reported that nicotinamide adenine dinucleotide phosphate oxidase and myeloperoxidase can be expressed in many types of inflammatory cells.<xref rid="R30" ref-type="bibr">30</xref><xref rid="R31" ref-type="bibr">31</xref> Both can be activated to induce chlorination reaction to produce hypochlorous acid<xref rid="R32" ref-type="bibr">32</xref> and ROS,<xref rid="R29" ref-type="bibr">29</xref> which has high oxidative activity, causing damage to substances such as lipids, proteins and DNA.<xref rid="R33" ref-type="bibr">33</xref> In subarachnoid hemorrhage, neutrophil oxidases from inflammatory sources such as nicotinamide adenine dinucleotide phosphate oxidase and myeloperoxidase can act as interaction points between neuroinflammation and oxidative stress, which deserve further study. At the same time, oxidative stress could also aggravate inflammatory damage, heme can activate neutrophils and microglia, promote the release of inflammatory factors and the expression of ROS.<xref rid="R34" ref-type="bibr">34</xref></p><p>Neuroinflammation can lead to the occurrence and development of oxidative stress, and the products of oxidative stress can also aggravate the infiltration of inflammation, which lead to a poor prognosis of traumatic neurological diseases. For the treatment of patients, perhaps more attention should be paid to such &#x0201c;interaction points&#x0201d;, so as to more effectively inhibit the development of brain injury. With the advancement of basic medicine and clinical medicine, new therapies to improve the prognosis of patients with traumatic neurological disorders have a wider applied prospect.</p><p>
<bold>Delivery of methane</bold>
</p><p><bold><italic toggle="yes">Inhalation of methane:</italic></bold> Methane itself is a non-toxic gas, which can be transported into the human body through a ventilator or a mask. Strifler and others<xref rid="R35" ref-type="bibr">35</xref> found that 2.2% methane inhalation could significantly reduce the severity of hepatic ischemia/reperfusion injury. A study by Boros and others<xref rid="R4" ref-type="bibr">4</xref> had shown that the gas mixture of oxygen and methane (21% oxygen + 2.5% methane) was safe for rodents. The hybrid gas of methane and air would explode when igniting. The safe limit for methane inhalation is 25% to 30%,<xref rid="R36" ref-type="bibr">36</xref> which has become the limitation of methane in clinical applications. Therefore, choosing reliable tools for using and storing methane is very important.</p><p><bold><italic toggle="yes">Injection of MS:</italic></bold> Due to the volatile characteristics of methane, MS under high-pressure conditions has similar properties.<xref rid="R9" ref-type="bibr">9</xref> This form is easy to store and transport. In addition, delivering methane into the body by intraperitoneal injection can increase its safety and accuracy. The MS injection method in the research literature can be summarized as follows, dissolving methane into the normal saline, and then pressing it at 0.4 or 0.6 MPa for 4 or 8 hours to reach the level of saturation and putting it at 4&#x000b0;C to store.<xref rid="R7" ref-type="bibr">7</xref><xref rid="R9" ref-type="bibr">9</xref><xref rid="R10" ref-type="bibr">10</xref> It is worth mentioning that transporting nitric oxide to the body in the form of isosorbide dinitrate, can relax the smooth muscle of the blood vessels and relieve the patient&#x02019;s symptoms.<xref rid="R37" ref-type="bibr">37</xref> Therefore, another methane transmission method can be explored by oral methane or developing &#x0201c;methane pills.&#x0201d; The intrathecal injection is also a way of administration by the nervous system, and whether methane can be administered by intrathecal injection is worth further studying.<xref rid="R38" ref-type="bibr">38</xref><xref rid="R39" ref-type="bibr">39</xref> Further clarification of the dose dependence of methane will provide the basis for its clinical application.</p><p><bold>Conclusion:</bold> This article reviews the related mechanisms by which methane exerts a neuroprotective role in traumatic neurological diseases and briefly elaborates some commonalities between the three diseases. Secondary injury associated with traumatic nervous system disease is the main cause of death and disability after admission. But the current clinical treatment is still mainly using surgery to relieve post-traumatic compression,<xref rid="R40" ref-type="bibr">40</xref> or using hypothermia therapy to reduce brain metabolism,<xref rid="R41" ref-type="bibr">41</xref> but there are no effective drugs to treat them. Although some promising neuroprotective therapies have been developed, they have not been translated into the clinic unfortunately, and the prognosis of patients urgently needs to be further improved.</p><p>In the process of searching the literature, we found that methane can play a neuroprotective role in the progression of traumatic nervous system diseases by inhibiting oxidative stress, neuroinflammation and apoptosis (<bold><xref rid="mgr.mgr_23_23-F1" ref-type="fig">Figure 1</xref></bold>), but the connection between them is very complex and lacks a clear and systematic mechanism. Iron deposition, lipid accumulation, and oxidative stress have been reported to be secondary injuries following traumatic injuries to the central nervous system, in which ferroptosis is the key point connecting all such secondary injuries.<xref rid="R42" ref-type="bibr">42</xref> In basic experiments, inhibition of ferroptosis has shown significant efficacy in protecting against neurotraumatic injury,<xref rid="R42" ref-type="bibr">42</xref> it has been reported that mitophagy plays a protective role in traumatic neurological diseases, and upregulating mitophagy to reduce downstream cascade reactions, such as oxidative damage, inflammatory response, and cell death, may improve neurological dysfunction.<xref rid="R43" ref-type="bibr">43</xref><xref rid="R44" ref-type="bibr">44</xref> Mitophagy and ferroptosis may be the key mechanisms of the connection. Therefore, it is bold to imagine that the two may be new targets for methane. In addition, except for the Wnt pathway and the Janus kinase 1/signal transducer and activator of transcription 1/ nuclear factor-KB-P65 pathway,<xref rid="R13" ref-type="bibr">13</xref> the phosphoinositide 3-kinase/AKT pathway,<xref rid="R45" ref-type="bibr">45</xref> the nuclear factor erythroid 2-related factor 2 pathway,<xref rid="R8" ref-type="bibr">8</xref> the nuclear factor-&#x003ba;&#x00392; and the mitogen-activated protein kinase pathway<xref rid="R46" ref-type="bibr">46</xref> have been confirmed to be involved in the neuroprotective effect of methane, indicating that the beneficial effects of methane are synergistic through a variety of signal-guided pathways, and the next step may be to verify whether these pathways mediate the role of methane in traumatic neurological diseases. Clarifying the connection between the guiding pathways of methane action and its interaction points has great significance for making up for the deficiencies in neuroprotective therapy for traumatic neurological diseases in clinical practice.</p><fig position="float" id="mgr.mgr_23_23-F1"><label>Figure 1</label><caption><p>Possible neuroprotective mechanisms of methane.</p><p>Note: Created with BioRender.com. CH<sub>4</sub>: Methane; GSH: glutathione; Iba-1: ionized calcium binding adaptor molecule-1; IL: interleukin; iNOS: inducible nitric oxide synthase; MDA: malondialdehyde; ROS: reactive oxygen species; SOD: superoxide dismutase; TNF: tumor necrosis factor.</p></caption><graphic xlink:href="MGR-14-159-g001" position="float"/></fig></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="R1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>ZH</given-names></name>
<name><surname>Ning</surname><given-names>K</given-names></name>
<name><surname>Ander</surname><given-names>BP</given-names></name>
<name><surname>Sun</surname><given-names>XJ</given-names></name></person-group><article-title>Therapeutic effect of methane and its mechanism in disease treatment</article-title><source>J Zhejiang Univ Sci B</source><year>2020</year><volume>21</volume><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="pmid">32748575</pub-id>
</element-citation></ref><ref id="R2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jia</surname><given-names>Y</given-names></name>
<name><surname>Li</surname><given-names>Z</given-names></name>
<name><surname>Feng</surname><given-names>Y</given-names></name>
<etal/></person-group><article-title>Methane-rich saline ameliorates sepsis-induced acute kidney injury through anti-inflammation, antioxidative, and antiapoptosis effects by regulating endoplasmic reticulum stress</article-title><source>Oxid Med Cell Longev</source><year>2018</year><volume>2018</volume><fpage>4756846</fpage><pub-id pub-id-type="pmid">30581532</pub-id>
</element-citation></ref><ref id="R3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Liu</surname><given-names>W</given-names></name>
<name><surname>Wang</surname><given-names>D</given-names></name>
<name><surname>Tao</surname><given-names>H</given-names></name>
<name><surname>Sun</surname><given-names>X</given-names></name></person-group><article-title>Is methane a new therapeutic gas?</article-title><source>Med Gas Res</source><year>2012</year><volume>2</volume><fpage>25</fpage><pub-id pub-id-type="pmid">23009320</pub-id>
</element-citation></ref><ref id="R4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Boros</surname><given-names>M</given-names></name>
<name><surname>Ghyczy</surname><given-names>M</given-names></name>
<name><surname>&#x000c9;rces</surname><given-names>D</given-names></name>
<etal/></person-group><article-title>The anti-inflammatory effects of methane</article-title><source>Crit Care Med</source><year>2012</year><volume>40</volume><fpage>1269</fpage><lpage>1278</lpage><pub-id pub-id-type="pmid">22336723</pub-id>
</element-citation></ref><ref id="R5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>Z</given-names></name>
<name><surname>Chen</surname><given-names>O</given-names></name>
<name><surname>Zhang</surname><given-names>R</given-names></name>
<etal/></person-group><article-title>Methane attenuates hepatic ischemia/ reperfusion injury in rats through antiapoptotic, anti-inflammatory, and antioxidative actions</article-title><source>Shock</source><year>2015</year><volume>44</volume><fpage>181</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">26009821</pub-id>
</element-citation></ref><ref id="R6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>B</given-names></name>
<name><surname>Tian</surname><given-names>X</given-names></name>
<name><surname>Li</surname><given-names>G</given-names></name>
<etal/></person-group><article-title>Methane inhalation protects against lung ischemia-reperfusion injury in rats by regulating pulmonary surfactant via the Nrf2 pathway</article-title><source>Front Physiol</source><year>2021</year><volume>12</volume><fpage>615974</fpage><pub-id pub-id-type="pmid">34054564</pub-id>
</element-citation></ref><ref id="R7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>W</given-names></name>
<name><surname>Huang</surname><given-names>X</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
<etal/></person-group><article-title>Methane suppresses microglial activation related to oxidative, inflammatory, and apoptotic injury during spinal cord injury in rats</article-title><source>Oxid Med Cell Longev</source><year>2017</year><volume>2017</volume><fpage>2190897</fpage><pub-id pub-id-type="pmid">28740568</pub-id>
</element-citation></ref><ref id="R8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>L</given-names></name>
<name><surname>Yao</surname><given-names>Y</given-names></name>
<name><surname>He</surname><given-names>R</given-names></name>
<etal/></person-group><article-title>Methane ameliorates spinal cord ischemia-reperfusion injury in rats: Antioxidant, anti-inflammatory and anti-apoptotic activity mediated by Nrf2 activation</article-title><source>Free Radic Biol Med</source><year>2017</year><volume>103</volume><fpage>69</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">28007572</pub-id>
</element-citation></ref><ref id="R9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>M</given-names></name>
<name><surname>Gao</surname><given-names>W</given-names></name>
<name><surname>Ji</surname><given-names>L</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Jiang</surname><given-names>W</given-names></name>
<name><surname>Ji</surname><given-names>W</given-names></name></person-group><article-title>Methane Saline ameliorates traumatic brain injury through anti-inflammatory, antiapoptotic, and antioxidative effects by activating the Wnt signalling pathway</article-title><source>Biomed Res Int</source><year>2020</year><volume>2020</volume><fpage>3852450</fpage><pub-id pub-id-type="pmid">33381552</pub-id>
</element-citation></ref><ref id="R10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>R</given-names></name>
<name><surname>Sun</surname><given-names>Q</given-names></name>
<name><surname>Xia</surname><given-names>F</given-names></name>
<etal/></person-group><article-title>Methane rescues retinal ganglion cells and limits retinal mitochondrial dysfunction following optic nerve crush</article-title><source>Exp Eye Res</source><year>2017</year><volume>159</volume><fpage>49</fpage><lpage>57</lpage><pub-id pub-id-type="pmid">28336261</pub-id>
</element-citation></ref><ref id="R11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Benton</surname><given-names>RL</given-names></name>
<name><surname>Hagg</surname><given-names>T</given-names></name></person-group><article-title>Vascular pathology as a potential therapeutic target in SCI</article-title><source>Transl Stroke Res</source><year>2011</year><volume>2</volume><fpage>556</fpage><lpage>574</lpage><pub-id pub-id-type="pmid">24323683</pub-id>
</element-citation></ref><ref id="R12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sterner</surname><given-names>RC</given-names></name>
<name><surname>Sterner</surname><given-names>RM</given-names></name></person-group><article-title>Immune response following traumatic spinal cord injury: pathophysiology and therapies</article-title><source>Front Immunol</source><year>2022</year><volume>13</volume><fpage>1084101</fpage><pub-id pub-id-type="pmid">36685598</pub-id>
</element-citation></ref><ref id="R13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wang</surname><given-names>FD</given-names></name>
<name><surname>Li</surname><given-names>J</given-names></name>
<name><surname>Zhai</surname><given-names>X</given-names></name>
<name><surname>Chen</surname><given-names>R</given-names></name>
<name><surname>Wang</surname><given-names>F</given-names></name></person-group><article-title>Methane-rich saline restores brain SOD activity and alleviates cognitive impairment in rats with traumatic brain injury</article-title><source>Food Sci Technol Campinas</source><year>2022</year><volume>42</volume><fpage>e54921</fpage></element-citation></ref><ref id="R14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>B</given-names></name>
<name><surname>Gao</surname><given-names>M</given-names></name>
<name><surname>Shen</surname><given-names>J</given-names></name>
<name><surname>He</surname><given-names>D</given-names></name></person-group><article-title>Inhaled methane protects rats against neurological dysfunction induced by cerebral ischemia and reperfusion injury: PI3K/Akt/HO-1 pathway involved</article-title><source>Arch Med Res</source><year>2017</year><volume>48</volume><fpage>520</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">29525064</pub-id>
</element-citation></ref><ref id="R15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>X</given-names></name>
<name><surname>Huang</surname><given-names>LY</given-names></name>
<name><surname>Pan</surname><given-names>HX</given-names></name>
<etal/></person-group><article-title>Bone marrow mesenchymal stem cells and exercise restore motor function following spinal cord injury by activating PI3K/AKT/mTOR pathway</article-title><source>Neural Regen Res</source><year>2023</year><volume>18</volume><fpage>1067</fpage><lpage>1075</lpage><pub-id pub-id-type="pmid">36254995</pub-id>
</element-citation></ref><ref id="R16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shi</surname><given-names>Y</given-names></name>
<name><surname>Fan</surname><given-names>C</given-names></name>
<name><surname>Li</surname><given-names>K</given-names></name>
<etal/></person-group><article-title>Fish oil fat emulsion alleviates traumatic brain injury in mice by regulation of microglia polarization</article-title><source>Neurosci Lett</source><year>2023</year><volume>804</volume><fpage>137217</fpage><pub-id pub-id-type="pmid">36997019</pub-id>
</element-citation></ref><ref id="R17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fan</surname><given-names>DF</given-names></name>
<name><surname>Hu</surname><given-names>HJ</given-names></name>
<name><surname>Sun</surname><given-names>Q</given-names></name>
<etal/></person-group><article-title>Neuroprotective effects of exogenous methane in a rat model of acute carbon monoxide poisoning</article-title><source>Brain Res</source><year>2016</year><volume>1633</volume><fpage>62</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">26711852</pub-id>
</element-citation></ref><ref id="R18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>X</given-names></name>
<name><surname>Gao</surname><given-names>C</given-names></name>
<name><surname>Yan</surname><given-names>Y</given-names></name>
<etal/></person-group><article-title>Ruxolitinib exerts neuroprotection via repressing ferroptosis in a mouse model of traumatic brain injury</article-title><source>Exp Neurol</source><year>2021</year><volume>342</volume><fpage>113762</fpage><pub-id pub-id-type="pmid">33991524</pub-id>
</element-citation></ref><ref id="R19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cui</surname><given-names>R</given-names></name>
<name><surname>Liu</surname><given-names>S</given-names></name>
<name><surname>Wang</surname><given-names>C</given-names></name>
<etal/></person-group><article-title>Methane-rich saline alleviates CA/CPR brain injury by inhibiting oxidative stress, microglial activation-induced inflammatory responses, and ER stress-mediated apoptosis</article-title><source>Oxid Med Cell Longev</source><year>2020</year><volume>2020</volume><fpage>8829328</fpage><pub-id pub-id-type="pmid">33149813</pub-id>
</element-citation></ref><ref id="R20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rao</surname><given-names>M</given-names></name>
<name><surname>Huang</surname><given-names>YK</given-names></name>
<name><surname>Liu</surname><given-names>CC</given-names></name>
<etal/></person-group><article-title>Aldose reductase inhibition decelerates optic nerve degeneration by alleviating retinal microglia activation</article-title><source>Sci Rep</source><year>2023</year><volume>13</volume><fpage>5592</fpage><pub-id pub-id-type="pmid">37019993</pub-id>
</element-citation></ref><ref id="R21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Borst</surname><given-names>K</given-names></name>
<name><surname>Dumas</surname><given-names>AA</given-names></name>
<name><surname>Prinz</surname><given-names>M</given-names></name></person-group><article-title>Microglia: Immune and non-immune functions</article-title><source>Immunity</source><year>2021</year><volume>54</volume><fpage>2194</fpage><lpage>2208</lpage><pub-id pub-id-type="pmid">34644556</pub-id>
</element-citation></ref><ref id="R22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Brennan</surname><given-names>FH</given-names></name>
<name><surname>Li</surname><given-names>Y</given-names></name>
<name><surname>Wang</surname><given-names>C</given-names></name>
<etal/></person-group><article-title>Microglia coordinate cellular interactions during spinal cord repair in mice</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><fpage>4096</fpage><pub-id pub-id-type="pmid">35835751</pub-id>
</element-citation></ref><ref id="R23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Witcher</surname><given-names>KG</given-names></name>
<name><surname>Bray</surname><given-names>CE</given-names></name>
<name><surname>Chunchai</surname><given-names>T</given-names></name>
<etal/></person-group><article-title>Traumatic brain injury causes chronic cortical inflammation and neuronal dysfunction mediated by microglia</article-title><source>J Neurosci</source><year>2021</year><volume>41</volume><fpage>1597</fpage><lpage>1616</lpage><pub-id pub-id-type="pmid">33452227</pub-id>
</element-citation></ref><ref id="R24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Grovola</surname><given-names>MR</given-names></name>
<name><surname>von</surname><given-names>Reyn C</given-names></name>
<name><surname>Loane</surname><given-names>DJ</given-names></name>
<name><surname>Cullen</surname><given-names>DK</given-names></name></person-group><article-title>Understanding microglial responses in large animal models of traumatic brain injury: an underutilized resource for preclinical and translational research</article-title><source>J Neuroinflammation</source><year>2023</year><volume>20</volume><fpage>67</fpage><pub-id pub-id-type="pmid">36894951</pub-id>
</element-citation></ref><ref id="R25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>L</given-names></name>
<name><surname>Zhu</surname><given-names>Z</given-names></name>
<name><surname>Hong</surname><given-names>L</given-names></name>
<name><surname>Qian</surname><given-names>Z</given-names></name>
<name><surname>Wang</surname><given-names>F</given-names></name>
<name><surname>Mao</surname><given-names>Z</given-names></name></person-group><article-title>ROS-responsive 18&#x003b2;-glycyrrhetic acid-conjugated polymeric nanoparticles mediate neuroprotection in ischemic stroke through HMGB1 inhibition and microglia polarization regulation</article-title><source>Bioact Mater</source><year>2023</year><volume>19</volume><fpage>38</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">35415314</pub-id>
</element-citation></ref><ref id="R26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Le</surname><given-names>K</given-names></name>
<name><surname>Song</surname><given-names>Z</given-names></name>
<name><surname>Deng</surname><given-names>J</given-names></name>
<etal/></person-group><article-title>Quercetin alleviates neonatal hypoxic-ischemic brain injury by inhibiting microglia-derived oxidative stress and TLR4-mediated inflammation</article-title><source>Inflamm Res</source><year>2020</year><volume>69</volume><fpage>1201</fpage><lpage>1213</lpage><pub-id pub-id-type="pmid">32944799</pub-id>
</element-citation></ref><ref id="R27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>X</given-names></name>
<name><surname>Zhang</surname><given-names>L</given-names></name>
<name><surname>Ye</surname><given-names>X</given-names></name>
<etal/></person-group><article-title>Nrf2/ARE pathway inhibits ROS-induced NLRP3 inflammasome activation in BV2 cells after cerebral ischemia reperfusion</article-title><source>Inflamm Res</source><year>2018</year><volume>67</volume><fpage>57</fpage><lpage>65</lpage><pub-id pub-id-type="pmid">28956063</pub-id>
</element-citation></ref><ref id="R28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zheng</surname><given-names>ZV</given-names></name>
<name><surname>Lyu</surname><given-names>H</given-names></name>
<name><surname>Lam</surname><given-names>SYE</given-names></name>
<name><surname>Lam</surname><given-names>PK</given-names></name>
<name><surname>Poon</surname><given-names>WS</given-names></name>
<name><surname>Wong</surname><given-names>GKC</given-names></name></person-group><article-title>The dynamics of microglial polarization reveal the resident neuroinflammatory responses after subarachnoid hemorrhage</article-title><source>Transl Stroke Res</source><year>2020</year><volume>11</volume><fpage>433</fpage><lpage>449</lpage><pub-id pub-id-type="pmid">31628642</pub-id>
</element-citation></ref><ref id="R29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duan</surname><given-names>J</given-names></name>
<name><surname>Gao</surname><given-names>S</given-names></name>
<name><surname>Tu</surname><given-names>S</given-names></name>
<name><surname>Lenahan</surname><given-names>C</given-names></name>
<name><surname>Shao</surname><given-names>A</given-names></name>
<name><surname>Sheng</surname><given-names>J</given-names></name></person-group><article-title>Pathophysiology and therapeutic potential of NADPH oxidases in ischemic stroke-induced oxidative stress</article-title><source>Oxid Med Cell Longev</source><year>2021</year><volume>2021</volume><fpage>6631805</fpage><pub-id pub-id-type="pmid">33777315</pub-id>
</element-citation></ref><ref id="R30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>X</given-names></name>
<name><surname>Liu</surname><given-names>W</given-names></name>
<name><surname>Li</surname><given-names>R</given-names></name>
<etal/></person-group><article-title>TSG-6 Attenuates oxidative stress-induced early brain injury in subarachnoid hemorrhage partly by the HO-1 and Nox2 pathways</article-title><source>J Stroke Cerebrovasc Dis</source><year>2020</year><volume>29</volume><fpage>104986</fpage><pub-id pub-id-type="pmid">32992175</pub-id>
</element-citation></ref><ref id="R31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>S</given-names></name>
<name><surname>Chen</surname><given-names>H</given-names></name>
<name><surname>Du</surname><given-names>Q</given-names></name>
<name><surname>Shen</surname><given-names>J</given-names></name></person-group><article-title>Targeting myeloperoxidase (MPO) mediated oxidative stress and inflammation for reducing brain ischemia injury: potential application of natural compounds</article-title><source>Front Physiol</source><year>2020</year><volume>11</volume><fpage>433</fpage><pub-id pub-id-type="pmid">32508671</pub-id>
</element-citation></ref><ref id="R32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hawkins</surname><given-names>CL</given-names></name>
<name><surname>Davies</surname><given-names>MJ</given-names></name></person-group><article-title>Role of myeloperoxidase and oxidant formation in the extracellular environment in inflammation-induced tissue damage</article-title><source>Free Radic Biol Med</source><year>2021</year><volume>172</volume><fpage>633</fpage><lpage>651</lpage><pub-id pub-id-type="pmid">34246778</pub-id>
</element-citation></ref><ref id="R33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hawkins</surname><given-names>CL</given-names></name></person-group><article-title>Hypochlorous acid-mediated modification of proteins and its consequences</article-title><source>Essays Biochem</source><year>2020</year><volume>64</volume><fpage>75</fpage><lpage>86</lpage><pub-id pub-id-type="pmid">31867603</pub-id>
</element-citation></ref><ref id="R34"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bozza</surname><given-names>MT</given-names></name>
<name><surname>Jeney</surname><given-names>V</given-names></name></person-group><article-title>Pro-inflammatory actions of heme and other hemoglobin-derived DAMPs</article-title><source>Front Immunol</source><year>2020</year><volume>11</volume><fpage>1323</fpage><pub-id pub-id-type="pmid">32695110</pub-id>
</element-citation></ref><ref id="R35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Strifler</surname><given-names>G</given-names></name>
<name><surname>Tuboly</surname><given-names>E</given-names></name>
<name><surname>Sz&#x000e9;l</surname><given-names>E</given-names></name>
<etal/></person-group><article-title>Inhaled methane limits the mitochondrial electron transport chain dysfunction during experimental liver ischemia-reperfusion injury</article-title><source>PLoS One</source><year>2016</year><volume>11</volume><fpage>e0146363</fpage><pub-id pub-id-type="pmid">26741361</pub-id>
</element-citation></ref><ref id="R36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ye</surname><given-names>ZH</given-names></name>
<name><surname>Fan</surname><given-names>DF</given-names></name>
<name><surname>Zhang</surname><given-names>TY</given-names></name></person-group><article-title>A narrative review of methane in treating neurological diseases</article-title><source>Med Gas Res</source><year>2023</year><volume>13</volume><fpage>161</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">37077112</pub-id>
</element-citation></ref><ref id="R37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Dallel</surname><given-names>R</given-names></name>
<name><surname>Descheemaeker</surname><given-names>A</given-names></name>
<name><surname>Luccarini</surname><given-names>P</given-names></name></person-group><article-title>Recurrent administration of the nitric oxide donor, isosorbide dinitrate, induces a persistent cephalic cutaneous hypersensitivity: A model for migraine progression</article-title><source>Cephalalgia</source><year>2018</year><volume>38</volume><fpage>776</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">28565942</pub-id>
</element-citation></ref><ref id="R38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Estrada</surname><given-names>JA</given-names></name>
<name><surname>Ducrocq</surname><given-names>GP</given-names></name>
<name><surname>Kim</surname><given-names>JS</given-names></name>
<name><surname>Kaufman</surname><given-names>MP</given-names></name></person-group><article-title>Intrathecal injection of brilliant blue G, a P2X7 antagonist, attenuates the exercise pressor reflex in rats</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2020</year><volume>319</volume><fpage>R223</fpage><lpage>R232</lpage><pub-id pub-id-type="pmid">32609538</pub-id>
</element-citation></ref><ref id="R39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ge</surname><given-names>Y</given-names></name>
<name><surname>Wu</surname><given-names>F</given-names></name>
<name><surname>Sun</surname><given-names>X</given-names></name>
<etal/></person-group><article-title>Intrathecal infusion of hydrogen-rich normal saline attenuates neuropathic pain via inhibition of activation of spinal astrocytes and microglia in rats</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><fpage>e97436</fpage><pub-id pub-id-type="pmid">24857932</pub-id>
</element-citation></ref><ref id="R40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nasi</surname><given-names>D</given-names></name>
<name><surname>Iaccarino</surname><given-names>C</given-names></name>
<name><surname>Romano</surname><given-names>A</given-names></name>
<etal/></person-group><article-title>Surgical management of traumatic supra and infratentorial extradural hematomas: our experience and systematic literature review</article-title><source>Neuro surg Rev</source><year>2020</year><volume>43</volume><fpage>893</fpage><lpage>901</lpage></element-citation></ref><ref id="R41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kaneko</surname><given-names>T</given-names></name>
<name><surname>Fujita</surname><given-names>M</given-names></name>
<name><surname>Yamashita</surname><given-names>S</given-names></name>
<etal/></person-group><article-title>Slow rewarming improved the neurological outcomes of prolonged mild therapeutic hypothermia in patients with severe traumatic brain injury and an evacuated hematoma</article-title><source>Sci Rep</source><year>2018</year><volume>8</volume><fpage>11630</fpage><pub-id pub-id-type="pmid">30072782</pub-id>
</element-citation></ref><ref id="R42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Li</surname><given-names>QS</given-names></name>
<name><surname>Jia</surname><given-names>YJ</given-names></name></person-group><article-title>Ferroptosis: a critical player and potential therapeutic target in traumatic brain injury and spinal cord injury</article-title><source>Neural Regen Res</source><year>2023</year><volume>18</volume><fpage>506</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">36018155</pub-id>
</element-citation></ref><ref id="R43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yang</surname><given-names>LY</given-names></name>
<name><surname>Greig</surname><given-names>NH</given-names></name>
<name><surname>Tweedie</surname><given-names>D</given-names></name>
<etal/></person-group><article-title>The p53 inactivators pifithrin-&#x003bc; and pifithrin-&#x003b1; mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy</article-title><source>Exp Neurol</source><year>2020</year><volume>324</volume><fpage>113135</fpage><pub-id pub-id-type="pmid">31778663</pub-id>
</element-citation></ref><ref id="R44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Han</surname><given-names>X</given-names></name>
<name><surname>Xu</surname><given-names>T</given-names></name>
<name><surname>Fang</surname><given-names>Q</given-names></name>
<etal/></person-group><article-title>Quercetin hinders microglial activation to alleviate neurotoxicity via the interplay between NLRP3 inflamma-some and mitophagy</article-title><source>Redox Biol</source><year>2021</year><volume>44</volume><fpage>102010</fpage><pub-id pub-id-type="pmid">34082381</pub-id>
</element-citation></ref><ref id="R45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>W</given-names></name>
<name><surname>Dong</surname><given-names>XY</given-names></name>
<name><surname>Huang</surname><given-names>R</given-names></name></person-group><article-title>Gut microbiota in ischemic stroke: role of gut bacteria-derived metabolites</article-title><source>Transl Stroke Res</source><year>2023</year><volume>14</volume><fpage>811</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">36279071</pub-id>
</element-citation></ref><ref id="R46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>D</given-names></name>
<name><surname>Li</surname><given-names>N</given-names></name>
<name><surname>Wang</surname><given-names>Y</given-names></name>
<etal/></person-group><article-title>Methane ameliorates post-operative cognitive dysfunction by inhibiting microglia NF-&#x003ba;B/MAPKs pathway and promoting IL-10 expression in aged mice</article-title><source>Int Immunopharmacol</source><year>2019</year><volume>71</volume><fpage>52</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">30877874</pub-id>
</element-citation></ref></ref-list></back></article>